4-(5-(4-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide,
mavacoxib,
Mavacoxib,
170569-88-7,
UNII-YFT7X7SR77,
PHA-739521,
YFT7X7SR77,
CHEMBL28527,
CHEBI:76207,
PHA 739,521,
4-[5-(4-FLUOROPHENYL)-3-(TRIFLUOROMETHYL)PYRAZOL-1-YL]BENZENE-1-SULFONAMIDE,
4-[5-(4-Fluoro-phenyl)-3-trifluoromethyl-pyrazol-1-yl]-benzenesulfonamide,
Mavacoxib [USAN:INN],
mavacoxibum,
4-(5-(4-Fluorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide,
4-[5-(4-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide,
Mavacoxib (USAN),
SCHEMBL212699,
CTK4D3615,
DTXSID90168880,
TTZNQDOUNXBMJV-UHFFFAOYSA-N,
ZINC3814698,
BDBM50057564,
AKOS030241943,
D04863,
E-6113,
4-[5-(4-fluorophenyl)-3-(trifluoromethyl)-1h-pyrazol-1-yl]-benzenesulfonamide,
Benzenesulfonamide, 4-(5-(4-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)-,
Trocoxil,
Mavacoxib [USAN],
CID9843089,
CS-O-10924,
4-[5-(4-fluorophenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide,